A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12000866

Download in:

View as

General Info

PMID
12000866